# Amycretin (zenagamtide) and kidney impairment: drug levels

Source: https://pepvault.app/research/amycretin-oldenburg-2026

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Amycretin](https://pepvault.app/research#amycretin)

Clinical trial · people

# Amycretin: similar drug exposure with kidney impairment in phase 1

Checked against the paper November 2026 Clinical trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this single-dose study, amycretin blood levels and side effects in people with reduced kidney function did not appear to differ in a clinically relevant way from those in people with normal kidneys.

- **Kind:** Clinical trial
- **Studied in:** People
- **Number studied:** 42
- **Published:** 2026
- **Journal:** Diabetes Obes Metab

## What they tested

Does reduced kidney function change how much amycretin (zenagamtide) ends up in the blood, or how safe and well tolerated it is?

## How the study was done

A phase 1 trial in 42 adults with a body mass index of 20.0-39.9 kg/m2. They were grouped by kidney function, estimated with the CKD-EPI 2021 creatinine-based formula: normal (14 people), and mild, moderate, severe impairment and end-stage kidney disease (7 per group). Each got a single 0.3 mg shot under the skin and was followed for 4 weeks.

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

The main measure was AUC, the total drug exposure in the blood over time: the geometric mean ranged from 520 to 715 h × nmol/L across the kidney impairment groups, compared with 543 h × nmol/L in the normal kidney group. Peak blood level (Cmax) ranged from 2.8 to 3.5 nmol across the impairment groups, versus 3.2 nmol/L in the normal group. Side effects that appeared during the study were reported in 30 people (71.4%); none were serious or severe, most were mild, and most often they were gastrointestinal (stomach and gut). The researchers concluded that kidney impairment did not appear to have a clinically relevant effect on the drug's blood levels or safety, and that dose adjustment did not seem warranted for these people.

## What it doesn’t show

Each person got a single 0.3 mg shot and was followed for 4 weeks, so the study did not test repeated dosing. Each kidney impairment group had just 7 people, and people were grouped by kidney function, not randomized.

## The paper

Oldenburg et al. Renal Impairment Does Not Affect Pharmacokinetics, Safety or Tolerability of Zenagamtide. Diabetes Obes Metab. 2026.

- [PubMed (PMID 42443140)](https://pubmed.ncbi.nlm.nih.gov/42443140/)
- [The paper (DOI 10.1111/dom.71096)](https://doi.org/10.1111/dom.71096)
- [ClinicalTrials.gov (NCT06559527)](https://clinicaltrials.gov/study/NCT06559527)

## The compound

- [Amycretin: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)

## With this study

### Amycretin

- [Amycretin: the full reference](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/amycretin-10mg)

### Studies

- [Amycretin: oral 50 mg arm cut HbA1c by 1.4% at 36 weeks](https://pepvault.app/research/amycretin-mora-2026)
- [Amycretin: HbA1c fell up to 1.7% at 36 weeks in type 2 diabetes](https://pepvault.app/research/amycretin-mora-2026-42532080)
- [Amycretin: 24.3% weight loss at 36 weeks in a phase 1b/2a trial](https://pepvault.app/research/amycretin-dahl-2025)
- [All 6 studies](https://pepvault.app/research#amycretin)

### Compared with

- [CagriSema vs Amycretin](https://pepvault.app/peptides/compare/cagrisema-vs-amycretin)
- [Semaglutide vs Amycretin](https://pepvault.app/peptides/compare/semaglutide-vs-amycretin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

## More studies on Amycretin

- [Amycretin: oral 50 mg arm cut HbA1c by 1.4% at 36 weeks](https://pepvault.app/research/amycretin-mora-2026) Randomized trial · people · 2026
- [Amycretin: HbA1c fell up to 1.7% at 36 weeks in type 2 diabetes](https://pepvault.app/research/amycretin-mora-2026-42532080) Randomized trial · people · 2026
- [Amycretin: 24.3% weight loss at 36 weeks in a phase 1b/2a trial](https://pepvault.app/research/amycretin-dahl-2025) Randomized trial · people · 2025
- [Amycretin: side effects all mild or moderate in first human trial](https://pepvault.app/research/amycretin-gasiorek-2025) Randomized trial · people · 2025
- [Amycretin cut body weight by 18% in obese rats over 21 days](https://pepvault.app/research/amycretin-kuhre-2025) Animal study · mice and rats · 2025
- [Every study on Amycretin](https://pepvault.app/research#amycretin)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Amycretin

- [Amycretin: the full reference](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/amycretin-10mg)

### Studies

- [Amycretin: oral 50 mg arm cut HbA1c by 1.4% at 36 weeks](https://pepvault.app/research/amycretin-mora-2026)
- [Amycretin: HbA1c fell up to 1.7% at 36 weeks in type 2 diabetes](https://pepvault.app/research/amycretin-mora-2026-42532080)
- [Amycretin: 24.3% weight loss at 36 weeks in a phase 1b/2a trial](https://pepvault.app/research/amycretin-dahl-2025)
- [All 6 studies](https://pepvault.app/research#amycretin)

### Compared with

- [CagriSema vs Amycretin](https://pepvault.app/peptides/compare/cagrisema-vs-amycretin)
- [Semaglutide vs Amycretin](https://pepvault.app/peptides/compare/semaglutide-vs-amycretin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Amycretin](https://pepvault.app/research#amycretin)

## The library

- [Amycretin](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
